From 2006 to 2015, insurance providers kept $9.1 billion more in taxpayer funds than they would have if their estimated cost forecasts for drug spending through Medicare had been more accurate. This eye-popping statistic comes courtesy of an in-depth report published Jan. 4 by the Wall-Street Journal.
From 2006 to 2015, insurance providers kept $9.1 billion more in taxpayer funds than they would have if their estimated cost forecasts for drug spending through Medicare had been more accurate. This eye-popping statistic comes courtesy of an in-depth report published Jan. 4 by the Wall-Street Journal.
